Vaxart announces results of survey on COVID-19 vaccine pill 08:06 VXRT Nearly 19M more American adults - about a third of those now refusing to get vaccinated - would get vaccinated if they could take a pill instead of getting a shot, according to a poll conducted by Quadrant Strategies and commissioned by Vaxart, Inc. The survey found that 23% of respondents said they do not plan to get vaccinated but nearly a third of them said they would if the vaccine were available as a pill instead of by a needle injection. The results suggest that about half of the additional vaccinated group would be drawn from minority populations, communities that have disproportionately not been vaccinated. The Centers for Disease Control and Prevention report only 12% of Hispanics, 9% of Blacks, and 6% of Asians have received vaccines as of April 21, 2021. Nearly a quarter of respondents said they are afraid of needles and that fear is found among all groups. The national survey of 1,500 Americans over the age of 18, conducted by Quadrant Strategies between March 17 and 24, also found that: 7 in 10 said they'd prefer taking a vaccine pill rather than getting injected with a vaccine. 7 in 10 said they'd prefer taking a pill at home rather than going somewhere to get vaccinated. 8 in 10 support speeding up the development of new vaccines that can respond more quickly to new virus strains as they appear. An overwhelming majority are worried that current vaccine development can't keep up with the new strains. This survey's findings come as the government has reported newer and more variants of Covid-19 in the United States. Vaxart recently completed the Phase 1 study of its oral tablet coronavirus vaccine: The study reached primary and secondary endpoints of safety and immunogenicity, respectively. VXA-CoV2-1 induced potent CD8+ T-cell responses that are potentially protective against the original as well as new and emerging Covid-19 strains.